Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

AIMS: The objective of our study was to define the interaction between either unfractionated heparin (UFH) or a low molecular weight heparin, reviparin (REV), and the pharmacodynamic profile of the GPIIb/IIIa-antagonists abciximab (ABC) or tirofiban (T). METHODS: Two studies each containing 18 healt...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Klinkhardt, Ute, Graff, Jochen, Westrup, Dagmar, Kirchmaier, Carl M, Esslinger, Hans-Ulrich, Breddin, Hans Klaus, Harder, Sebastian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2001
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014552/
https://ncbi.nlm.nih.gov/pubmed/11560562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.0306-5251.2001.01446.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak